Oct 14 (Reuters) – AbbVie Inc won the conditional
backing of an advisory committee of the European Medicines
Agency (EMA) on Friday for a drug to treat a form of blood
cancer.
The post UPDATE 1-EMA committee conditionally approves AbbVie leukaemia drug appeared first on NASDAQ.